By Dr. Anna Mazzucco January 8, 2015 Thank you for the opportunity to speak today at this very important meeting. My name is Dr. Anna Mazzucco, and I am speaking on behalf of the National Center for Health Research. I received my Ph.D. in cell biology from Harvard Medical School, and I conducted post-doctoral […]
Mammography overview: learn more about similarities and differences between traditional mammograms and the newer digital and 3D mammograms.
October 25, 2015. Politico. The Senate’s companion effort to the House-passed 21st Century Cures is struggling to navigate a dramatically different political reality than the one that helped rocket the medical innovation bill through the lower chamber over the summer.
October 22, 2015. Medscape Medical News. In approving new cancer drugs, the US Food and Drug Administration (FDA) is now heavily relying on surrogate markers of effectiveness, such as tumor shrinkage, instead of proof that an agent improves survival, according to a new analysis.
Comments of Members of the Patient, Consumer, and Public Health Coalition on “Testicular Toxicity: Evaluation During Drug Development – Guidance for Industry” [Docket No. FDA-2015-D-2306-0001] We appreciate the opportunity to provide feedback to the FDA on the evaluation of testicular toxicity during drug development. The recommendations in the draft guidance are very important and we […]